Clinical trial NCT02579980 - References

Sarcoma — Quantitative Imaging Biomarkers for Sarcoma

Citation(s)

•   Babsky AM, Topper S, Zhang H, Gao Y, James JR, Hekmatyar SK, Bansal N
  Evaluation of extra- and intracellular apparent diffusion coefficient of sodium in rat skeletal muscle: effects of prolonged ischemia. Magn Reson Med. 2008 Mar;59(3):485-91. doi: 10.1002/mrm.21568.
•   Bartolozzi C, Lencioni R, Caramella D, Mazzeo S, Ciancia EM
  Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging. AJR Am J Roentgenol. 1994 Apr;162(4):827-31.
•   Brunberg JA, Chenevert TL, McKeever PE, Ross DA, Junck LR, Muraszko KM, Dauser R, Pipe JG, Betley AT
  In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol. 1995 Feb;16(2):361-71. Erratum in: AJNR Am J Neuroradiol 1995 Jun-Jul;16(6):1384.
•   Castillo M, Arbelaez A, Smith JK, Fisher LL
  Diffusion-weighted MR imaging offers no advantage over routine noncontrast MR imaging in the detection of vertebral metastases. AJNR Am J Neuroradiol. 2000 May;21(5):948-53.
•   Castrucci M, Sironi S, De Cobelli F, Salvioni M, Del Maschio A
  Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization. Abdom Imaging. 1996 Nov-Dec;21(6):488-94.
•   Chenevert TL, Meyer CR, Moffat BA, Rehemtulla A, Mukherji SK, Gebarski SS, Quint DJ, Robertson PL, Lawrence TS, Junck L, Taylor JM, Johnson TD, Dong Q, Muraszko KM, Brunberg JA, Ross BD
  Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging. 2002 Oct;1(4):336-43. Review.
•   Chenevert TL, Stegman LD, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD
  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst. 2000 Dec 20;92(24):2029-36.
•   Devries AF, Griebel J, Kremser C, Judmaier W, Gneiting T, Kreczy A, Ofner D, Pfeiffer KP, Brix G, Lukas P
  Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res. 2001 Mar 15;61(6):2513-6.
•   Ei Khouli RH, Jacobs MA, Mezban SD, Huang P, Kamel IR, Macura KJ, Bluemke DA
  Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology. 2010 Jul;256(1):64-73. doi: 10.1148/radiol.10091367.
•   Evelhoch J, Garwood M, Vigneron D, Knopp M, Sullivan D, Menkens A, Clarke L, Liu G
  Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. Cancer Res. 2005 Aug 15;65(16):7041-4.
•   Evelhoch JL, LoRusso PM, He Z, DelProposto Z, Polin L, Corbett TH, Langmuir P, Wheeler C, Stone A, Leadbetter J, Ryan AJ, Blakey DC, Waterton JC
  Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126. Clin Cancer Res. 2004 Jun 1;10(11):3650-7.
•   Feydy A, Anract P, Tomeno B, Chevrot A, Drapé JL
  Assessment of vascular invasion by musculoskeletal tumors of the limbs: use of contrast-enhanced MR angiography. Radiology. 2006 Feb;238(2):611-21. Erratum in: Radiology. 2007 Mar;242(3):950.
•   Herneth AM, Friedrich K, Weidekamm C, Schibany N, Krestan C, Czerny C, Kainberger F
  Diffusion weighted imaging of bone marrow pathologies. Eur J Radiol. 2005 Jul;55(1):74-83. Review.
•   Herneth AM, Philipp MO, Naude J, Funovics M, Beichel RR, Bammer R, Imhof H
  Vertebral metastases: assessment with apparent diffusion coefficient. Radiology. 2002 Dec;225(3):889-94.
•   Hoskin PJ, Saunders MI, Goodchild K, Powell ME, Taylor NJ, Baddeley H
  Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol. 1999 Nov;72(863):1093-8.
•   Hosseinzadeh K, Schwarz SD
  Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging. 2004 Oct;20(4):654-61.
•   Hylton N
  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol. 2006 Jul 10;24(20):3293-8. Review.
•   Jacobs MA, Herskovits EH, Kim HS
  Uterine fibroids: diffusion-weighted MR imaging for monitoring therapy with focused ultrasound surgery--preliminary study. Radiology. 2005 Jul;236(1):196-203.
•   Jacobs MA, Ouwerkerk R, Kamel I, Bottomley PA, Bluemke DA, Kim HS
  Proton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study. J Magn Reson Imaging. 2009 Mar;29(3):649-56. doi: 10.1002/jmri.21677.
•   Jacobs MA, Ouwerkerk R, Wolff AC, Stearns V, Bottomley PA, Barker PB, Argani P, Khouri N, Davidson NE, Bhujwalla ZM, Bluemke DA
  Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technol Cancer Res Treat. 2004 Dec;3(6):543-50.
•   Jin G, An N, Jacobs MA, Li K
  The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Acad Radiol. 2010 Apr;17(4):456-63. doi: 10.1016/j.acra.2009.12.004.
•   Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF
  The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol. 2006 Mar;17(3):505-12.
•   Kawai A, Sugihara S, Kunisada T, Uchida Y, Inoue H
  Imaging assessment of the response of bone tumors to preoperative chemotherapy. Clin Orthop Relat Res. 1997 Apr;(337):216-25.
•   Knight RA, Ordidge RJ, Helpern JA, Chopp M, Rodolosi LC, Peck D
  Temporal evolution of ischemic damage in rat brain measured by proton nuclear magnetic resonance imaging. Stroke. 1991 Jun;22(6):802-8.
•   Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M
  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988 Aug;168(2):497-505.
•   Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M
  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986 Nov;161(2):401-7.
•   Marcus CD, Ladam-Marcus V, Cucu C, Bouché O, Lucas L, Hoeffel C
  Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol. 2009 Dec;72(3):217-38. doi: 10.1016/j.critrevonc.2008.07.012. Epub 2008 Aug 29. Review.
•   Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH
  Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst. 2005 Feb 2;97(3):172-87. Review.
•   Mintorovitch J, Moseley ME, Chileuitt L, Shimizu H, Cohen Y, Weinstein PR
  Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med. 1991 Mar;18(1):39-50.
•   Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, Norman D
  Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol. 1990 May;11(3):423-9.
•   Murakami T, Nakamura H, Hori S, Tomoda K, Mitani T, Nakanishi K, Hashimoto T, Tsuda K, Kozuka T, Monden M, et al
  Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA. Acta Radiol. 1993 Jul;34(4):399-403.
•   Padhani AR, Leach MO
  Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging. Abdom Imaging. 2005 May-Jun;30(3):324-41. Review.
•   Rehman S, Jayson GC
  Molecular imaging of antiangiogenic agents. Oncologist. 2005 Feb;10(2):92-103. Review.
•   Szafer A, Zhong J, Gore JC
  Theoretical model for water diffusion in tissues. Magn Reson Med. 1995 May;33(5):697-712.
•   Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM
  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999 Sep;10(3):223-32. Review.
•   Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M
  Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol. 2006 Aug;41(8):618-23.
•   Vanel D, Lacombe MJ, Couanet D, Kalifa C, Spielmann M, Genin J
  Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology. 1987 Jul;164(1):243-5.
•   Vanel D, Shapeero LG, Tardivon A, Western A, Guinebretière JM
  Dynamic contrast-enhanced MRI with subtraction of aggressive soft tissue tumors after resection. Skeletal Radiol. 1998 Sep;27(9):505-10.

Development of Quantitative Imaging Biomarkers for Evaluating Sarcoma Patients

Details for clinical trial NCT02579980